Rosetta Genomics to Host Business Update, Six Month Financials Conference Call on October 27, 2015

Rosetta Genomics Ltd.

today announced that following the close of the U.S. stock market on Monday, October 26, 2015, the Company will file its financial results for the six months ended June 30, 2015 on Form 6-K with the U.S. Securities and Exchange Commission ("SEC"). The Form 6-K will include unaudited consolidated financial statements, as well as additional information regarding the Company. The Form 6-K will be available at www.sec.gov and at www.rosettagenomics.com. Kenneth A. Berlin, President and Chief Executive Officer of Rosetta Genomics, and Ron Kalfus, Chief Financial Officer of Rosetta Genomics, will host a conference call on Tuesday,